Annual Meeting 8-K 2014


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 12, 2014
Biogen Idec Inc.
(Exact name of registrant as specified in its charter)
Delaware
0-19311
33-0112644
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

225 Binney Street, Cambridge, Massachusetts 02142
(Address of principal executive offices; Zip Code)
    
Registrant’s telephone number, including area code: (617) 679-2000
Not Applicable
(Former name or former address, if changed since last report.)
    
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 5.07     Submission of Matters to a Vote of Security Holders
On June 12, 2014, Biogen Idec Inc. (the “Company”) held its Annual Meeting of Stockholders. The final voting results for this meeting are as follows:
1.
Stockholders elected eleven nominees to the Board of Directors to serve for a one-year term extending until the 2015 annual meeting of stockholders and their successors are duly elected and qualified, with the votes cast as follows:
Nominee
 
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
Alexander J. Denner
 
196,667,306

 
310,472

 
271,681

 
14,078,445

Caroline D. Dorsa
 
196,801,262

 
176,540

 
271,657

 
14,078,445

Nancy L. Leaming
 
196,766,149

 
204,430

 
278,880

 
14,078,445

Richard C. Mulligan
 
196,755,686

 
220,614

 
273,159

 
14,078,445

Robert W. Pangia
 
195,548,566

 
1,428,645

 
272,248

 
14,078,445

Stelios Papadopoulos
 
193,367,812

 
2,895,180

 
986,467

 
14,078,445

Brian S. Posner
 
195,766,919

 
1,211,574

 
270,966

 
14,078,445

Eric K. Rowinsky
 
195,531,645

 
1,443,123

 
274,691

 
14,078,445

George A. Scangos
 
196,753,459

 
219,616

 
276,384

 
14,078,445

Lynn Schenk
 
195,574,811

 
1,411,765

 
262,883

 
14,078,445

Stephen A. Sherwin
 
179,748,152

 
17,223,686

 
277,621

 
14,078,445

2.
Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014, with the votes cast as follows: 209,682,090 votes for; 1,321,500 votes against; 324,314 abstentions; 0 broker non-votes.
3.
Stockholders approved the advisory vote on executive compensation, with the votes cast as follows: 191,451,491 votes for; 5,185,972 votes against; 611,996 abstentions; 14,078,445 broker non-votes.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BIOGEN IDEC INC.


By: /s/ Robert A. Licht
Robert A. Licht
Senior Vice President


Date: June 13, 2014